Home > Insider Trading > Filing (0000950142-17-002235)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1581720	Loxo Oncology Inc.	LOXO	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1172252	N Andrew Schiff	888 Seventh Avenue, 12Th Floor New York NY 10106	No	No	Yes	No
1250195	Steve Elms	888 Seventh Avenue 12Th Floor New York NY 10106	Yes	No	Yes	No
1297291	J Dennis Purcell	888 Seventh Avenue, 12Th Floor New York NY 10106	No	No	Yes	No
1444717	Aisling Capital Iii Lp	888 Seventh Avenue, 12Th Floor New York NY 10106	No	No	Yes	No
1532634	Aisling Capital Partners Iii Lp	Aisling Capital Llc 888 Seventh Avenue 12Th Floor New York NY 10106	No	No	Yes	No
1532635	Aisling Capital Partners Iii Llc	Aisling Capital Llc 888 Seventh Avenue 12Th Floor New York NY 10106	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-12-19	250,000	$80.50	3,438,920	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The securities are directly held by Aisling Capital III, LP ("Aisling"), and indirectly held by Aisling Capital Partners III, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners III LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members and partners (collectively, the "Managers") of Aisling GP and Aisling Partners. The Managers of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms. Mr. Elms is a member of the Issuer's Board of Directors. Dr. Joshua Bilenker, the Issuer's President and Chief Executive Officer, is a member of the Issuer's Board of Directors and an Operating Partner of Aisling GP. Mr. Elms is a member of the investment committee (the "Investment Committee") of Aisling GP. The Investment Committee has voting and dispositive power over the shares held by Aisling.